Results 11 to 20 of about 1,055,250 (236)
Anticholinergic Drugs in Nonallergic Rhinitis [PDF]
World Allergy Organization Journal, 2009 Background: The parasympathetic nervous system contributes to the pathophysiology of multiple forms of allergic and nonallergic rhinitis. Stimulation of the parasympathetic nervous system leads to glandular activation, which produces watery secretions ...
Robert Naclerio, MD
doaj +4 more sources
Prevalence of the consumption of anticholinergic drugs in HIV patients [PDF]
Farmacia Hospitalaria, 2018 Objective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to determine anticholinergic risk using the ACB and ARS scales; and to determine if these patients use any type of benzodiazepine.
Ricardo Zafra-Morales +5 more
doaj +5 more sources
A Universal Pharmacological-Based List of Drugs with Anticholinergic Activity [PDF]
Pharmaceutics, 2023 Anticholinergic burden tools have relevant pharmacological gaps that may explain their limited predictive ability for clinical outcomes. The aim of this study was to provide a universal pharmacological-based list of drugs with their documented affinity ...
Marta Lavrador +5 more
doaj +3 more sources
Anticholinergic drugs and risk of dementia: Time for action? [PDF]
Pharmacol Res Perspect, 2021 Evidence suggests that the prescription of bladder anticholinergics is increasing. Recent studies have accentuated concerns about whether certain prescribed medications could increase risk of dementia, including anticholinergic drugs, and specifically ...
Bell B +5 more
europepmc +2 more sources
Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment. [PDF]
Eur J Neurol, 2022 BackgroundAnticholinergic (AC) medication use is associated with cognitive decline and dementia, which may be related to an AC induced central hypocholinergic state, but the exact mechanisms remain to be understood.
Meng D +4 more
europepmc +2 more sources
International Journal of Population Data Science, 2022 Background Anticholinergic drugs block muscarinic receptors in the body. They are commonly prescribed for a variety of indications and their use has previously been associated with dementia and cognitive decline.
Jure Mur +4 more
doaj +1 more source
Analysis of drug scale with anticholinergic activity
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2023 Objective: To identify the anticholinergic drug scales and analyse the agreement regarding the drugs included. Methods: This is a descriptive study on scales of drugs with anticholinergic activity.
Jennifer Soares OLIVEIRA +1 more
doaj +1 more source
BMJ Open, 2021 Objectives The aims of our study were to examine the anticholinergic drug use and to assess the association between anticholinergic burden and cognitive function in the multimorbid elderly patients of the MultiCare cohort.Setting MultiCare was conducted ...
Hans-Helmut König +15 more
doaj +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2020 Objectives: Identify drugs from the National List of Essential Medicines-Rename 2018 that have anticholinergic activity and scales of anticholinergic activity available for use in clinical practice.
Mariana S. LIMA, Adriano M. REIS
doaj +1 more source